APO Research
Talk to an analyst

APO RESEARCH · REPORT

IVIg Liquid

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global IVIg Liquid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchIVIg Liquid Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal IVIg Liquid Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal IVIg Liquid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IVIg Liquid Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal IVIg Liquid Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global IVIg Liquid market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IVIg Liquid include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global IVIg Liquid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IVIg Liquid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IVIg Liquid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the IVIg Liquid market size, projected growth trends, production technologies, key applications, and end-use industries.

IVIg Liquid Segment by Company

Takeda

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

Octapharma

LFB Group

Kedrion

Grifols

CSL

CNBG

CBPO

BPL

Biotest

IVIg Liquid Segment by Type

50ml

25ml

IVIg Liquid Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

IVIg Liquid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVIg Liquid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IVIg Liquid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVIg Liquid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the IVIg Liquid market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IVIg Liquid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of IVIg Liquid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of IVIg Liquid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. IVIg Liquid Industry Trends Table 2. IVIg Liquid Industry Drivers Table 3. IVIg Liquid Industry Opportunities and Challenges Table 4. IVIg Liquid Industry Restraints Table 5. Global IVIg Liquid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global IVIg Liquid Revenue Market Share by Manufacturers (2021-2026) Table 7. Global IVIg Liquid Sales by Manufacturers (k units) & (2021-2026) Table 8. Global IVIg Liquid Sales Market Share by Manufacturers Table 9. Global IVIg Liquid Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global IVIg Liquid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global IVIg Liquid Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global IVIg Liquid Manufacturers, Product Type & Application Table 13. Global IVIg Liquid Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global IVIg Liquid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50ml Table 17. Major Manufacturers of 25ml Table 18. Global IVIg Liquid Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global IVIg Liquid Sales by Type (2021-2026) & (k units) Table 20. Global IVIg Liquid Sales by Type (2027-2032) & (k units) Table 21. Global IVIg Liquid Sales Market Share by Type (2021-2026) Table 22. Global IVIg Liquid Sales Market Share by Type (2027-2032) Table 23. Global IVIg Liquid Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global IVIg Liquid Revenue by Type (2021-2026) & (k units) Table 25. Global IVIg Liquid Revenue by Type (2027-2032) & (k units) Table 26. Global IVIg Liquid Revenue Market Share by Type (2021-2026) Table 27. Global IVIg Liquid Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Autoimmune Disease Table 29. Major Manufacturers of Immunodeficiency Table 30. Major Manufacturers of Acute Infection Table 31. Global IVIg Liquid Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global IVIg Liquid Sales by Application (2021-2026) & (k units) Table 33. Global IVIg Liquid Sales by Application (2027-2032) & (k units) Table 34. Global IVIg Liquid Sales Market Share by Application (2021-2026) Table 35. Global IVIg Liquid Sales Market Share by Application (2027-2032) Table 36. Global IVIg Liquid Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global IVIg Liquid Revenue by Application (2021-2026) & (k units) Table 38. Global IVIg Liquid Revenue by Application (2027-2032) & (k units) Table 39. Global IVIg Liquid Revenue Market Share by Application (2021-2026) Table 40. Global IVIg Liquid Revenue Market Share by Application (2027-2032) Table 41. Global IVIg Liquid Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global IVIg Liquid Sales by Region (2021-2026) & (k units) Table 43. Global IVIg Liquid Sales Market Share by Region (2021-2026) Table 44. Global IVIg Liquid Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global IVIg Liquid Sales Forecasted Market Share by Region (2027-2032) Table 46. North America IVIg Liquid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America IVIg Liquid Sales by Country (2021-2026) & (k units) Table 48. North America IVIg Liquid Sales by Country (2027-2032) & (k units) Table 49. Europe IVIg Liquid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe IVIg Liquid Sales by Country (2021-2026) & (k units) Table 51. Europe IVIg Liquid Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific IVIg Liquid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific IVIg Liquid Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific IVIg Liquid Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa IVIg Liquid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa IVIg Liquid Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa IVIg Liquid Sales by Country (2027-2032) & (k units) Table 58. Global IVIg Liquid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global IVIg Liquid Revenue by Region (2021-2026) & (US$ Million) Table 60. Global IVIg Liquid Revenue by Region (2027-2032) & (US$ Million) Table 61. Global IVIg Liquid Revenue Market Share by Region (2021-2026) Table 62. Global IVIg Liquid Revenue Market Share by Region (2027-2032) Table 63. Takeda Company Information Table 64. Takeda Business Overview Table 65. Takeda IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda IVIg Liquid Product Portfolio Table 67. Takeda Recent Development Table 68. Sichuan Yuanda Shuyang Company Information Table 69. Sichuan Yuanda Shuyang Business Overview Table 70. Sichuan Yuanda Shuyang IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio Table 72. Sichuan Yuanda Shuyang Recent Development Table 73. Shanghai RAAS Company Information Table 74. Shanghai RAAS Business Overview Table 75. Shanghai RAAS IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shanghai RAAS IVIg Liquid Product Portfolio Table 77. Shanghai RAAS Recent Development Table 78. Hualan Bio Company Information Table 79. Hualan Bio Business Overview Table 80. Hualan Bio IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hualan Bio IVIg Liquid Product Portfolio Table 82. Hualan Bio Recent Development Table 83. Octapharma Company Information Table 84. Octapharma Business Overview Table 85. Octapharma IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Octapharma IVIg Liquid Product Portfolio Table 87. Octapharma Recent Development Table 88. LFB Group Company Information Table 89. LFB Group Business Overview Table 90. LFB Group IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. LFB Group IVIg Liquid Product Portfolio Table 92. LFB Group Recent Development Table 93. Kedrion Company Information Table 94. Kedrion Business Overview Table 95. Kedrion IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Kedrion IVIg Liquid Product Portfolio Table 97. Kedrion Recent Development Table 98. Grifols Company Information Table 99. Grifols Business Overview Table 100. Grifols IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Grifols IVIg Liquid Product Portfolio Table 102. Grifols Recent Development Table 103. CSL Company Information Table 104. CSL Business Overview Table 105. CSL IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. CSL IVIg Liquid Product Portfolio Table 107. CSL Recent Development Table 108. CNBG Company Information Table 109. CNBG Business Overview Table 110. CNBG IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. CNBG IVIg Liquid Product Portfolio Table 112. CNBG Recent Development Table 113. CBPO Company Information Table 114. CBPO Business Overview Table 115. CBPO IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. CBPO IVIg Liquid Product Portfolio Table 117. CBPO Recent Development Table 118. BPL Company Information Table 119. BPL Business Overview Table 120. BPL IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. BPL IVIg Liquid Product Portfolio Table 122. BPL Recent Development Table 123. Biotest Company Information Table 124. Biotest Business Overview Table 125. Biotest IVIg Liquid Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Biotest IVIg Liquid Product Portfolio Table 127. Biotest Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. IVIg Liquid Distributors List Table 131. IVIg Liquid Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. IVIg Liquid Product Image Figure 2. Global IVIg Liquid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IVIg Liquid Market Size (2021-2032) & (US$ Million) Figure 4. Global IVIg Liquid Sales (2021-2032) & (k units) Figure 5. Global IVIg Liquid Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 IVIg Liquid Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50ml Image Figure 9. 25ml Image Figure 10. Global IVIg Liquid Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global IVIg Liquid Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global IVIg Liquid Sales Market Share by Type (2021-2032) Figure 13. Global IVIg Liquid Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global IVIg Liquid Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global IVIg Liquid Revenue Market Share by Type (2021-2032) Figure 16. Autoimmune Disease Image Figure 17. Immunodeficiency Image Figure 18. Acute Infection Image Figure 19. Global IVIg Liquid Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global IVIg Liquid Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global IVIg Liquid Sales Market Share by Application (2021-2032) Figure 22. Global IVIg Liquid Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global IVIg Liquid Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global IVIg Liquid Revenue Market Share by Application (2021-2032) Figure 25. North America IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America IVIg Liquid Sales Market Share by Country (2021-2032) Figure 27. U.S. IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe IVIg Liquid Sales Market Share by Country (2021-2032) Figure 32. Germany IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 33. France IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific IVIg Liquid Sales Market Share by Country (2021-2032) Figure 39. China IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 43. India IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa IVIg Liquid Sales Market Share by Country (2021-2032) Figure 47. Brazil IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile IVIg Liquid Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global IVIg Liquid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global IVIg Liquid Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America IVIg Liquid Revenue (2021-2032) & (US$ Million) Figure 58. North America IVIg Liquid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe IVIg Liquid Revenue (2021-2032) & (US$ Million) Figure 60. Europe IVIg Liquid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific IVIg Liquid Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific IVIg Liquid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa IVIg Liquid Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa IVIg Liquid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. IVIg Liquid Value Chain Figure 66. Manufacturing Cost Structure Figure 67. IVIg Liquid Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 25ml
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Takeda
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • CNBG
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global IVIg Liquid Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global IVIg Liquid Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global IVIg Liquid Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global IVIg Liquid Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global IVIg Liquid Market Dynamics
  1. 2.1 IVIg Liquid Industry Trends
  2. 2.2 IVIg Liquid Industry Drivers
  3. 2.3 IVIg Liquid Industry Opportunities and Challenges
  4. 2.4 IVIg Liquid Industry Restraints
3 IVIg Liquid Market by Manufacturers
  1. 3.1 Global IVIg Liquid Revenue by Manufacturers (2021-2026)
  2. 3.2 Global IVIg Liquid Sales by Manufacturers (2021-2026)
  3. 3.3 Global IVIg Liquid Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global IVIg Liquid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IVIg Liquid Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global IVIg Liquid Manufacturers, Product Type & Application
  7. 3.7 Global IVIg Liquid Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IVIg Liquid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IVIg Liquid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IVIg Liquid Tier 1, Tier 2, and Tier 3
4 IVIg Liquid Market by Type
  1. 4.1 IVIg Liquid Type Introduction
  2. 4.1.1 50ml
  3. 4.1.2 25ml
  4. 4.2 Global IVIg Liquid Sales by Type
  5. 4.2.1 Global IVIg Liquid Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global IVIg Liquid Sales by Type (2021-2032)
  7. 4.2.3 Global IVIg Liquid Sales Market Share by Type (2021-2032)
  8. 4.3 Global IVIg Liquid Revenue by Type
  9. 4.3.1 Global IVIg Liquid Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global IVIg Liquid Revenue by Type (2021-2032)
  11. 4.3.3 Global IVIg Liquid Revenue Market Share by Type (2021-2032)
5 IVIg Liquid Market by Application
  1. 5.1 IVIg Liquid Application Introduction
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global IVIg Liquid Sales by Application
  6. 5.2.1 Global IVIg Liquid Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IVIg Liquid Sales by Application (2021-2032)
  8. 5.2.3 Global IVIg Liquid Sales Market Share by Application (2021-2032)
  9. 5.3 Global IVIg Liquid Revenue by Application
  10. 5.3.1 Global IVIg Liquid Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global IVIg Liquid Revenue by Application (2021-2032)
  12. 5.3.3 Global IVIg Liquid Revenue Market Share by Application (2021-2032)
6 Global IVIg Liquid Sales by Region
  1. 6.1 Global IVIg Liquid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IVIg Liquid Sales by Region (2021-2032)
  3. 6.2.1 Global IVIg Liquid Sales by Region (2021-2026)
  4. 6.2.2 Global IVIg Liquid Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America IVIg Liquid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America IVIg Liquid Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe IVIg Liquid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe IVIg Liquid Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific IVIg Liquid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific IVIg Liquid Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa IVIg Liquid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa IVIg Liquid Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global IVIg Liquid Revenue by Region
  1. 7.1 Global IVIg Liquid Revenue by Region
  2. 7.1.1 Global IVIg Liquid Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global IVIg Liquid Revenue by Region (2021-2026)
  4. 7.1.3 Global IVIg Liquid Revenue by Region (2027-2032)
  5. 7.1.4 Global IVIg Liquid Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America IVIg Liquid Revenue (2021-2032)
  8. 7.2.2 North America IVIg Liquid Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe IVIg Liquid Revenue (2021-2032)
  11. 7.3.2 Europe IVIg Liquid Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific IVIg Liquid Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific IVIg Liquid Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa IVIg Liquid Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa IVIg Liquid Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda IVIg Liquid Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Sichuan Yuanda Shuyang
  8. 8.2.1 Sichuan Yuanda Shuyang Company Information
  9. 8.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 8.2.3 Sichuan Yuanda Shuyang IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio
  12. 8.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 8.3 Shanghai RAAS
  14. 8.3.1 Shanghai RAAS Company Information
  15. 8.3.2 Shanghai RAAS Business Overview
  16. 8.3.3 Shanghai RAAS IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai RAAS IVIg Liquid Product Portfolio
  18. 8.3.5 Shanghai RAAS Recent Developments
  19. 8.4 Hualan Bio
  20. 8.4.1 Hualan Bio Company Information
  21. 8.4.2 Hualan Bio Business Overview
  22. 8.4.3 Hualan Bio IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hualan Bio IVIg Liquid Product Portfolio
  24. 8.4.5 Hualan Bio Recent Developments
  25. 8.5 Octapharma
  26. 8.5.1 Octapharma Company Information
  27. 8.5.2 Octapharma Business Overview
  28. 8.5.3 Octapharma IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Octapharma IVIg Liquid Product Portfolio
  30. 8.5.5 Octapharma Recent Developments
  31. 8.6 LFB Group
  32. 8.6.1 LFB Group Company Information
  33. 8.6.2 LFB Group Business Overview
  34. 8.6.3 LFB Group IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LFB Group IVIg Liquid Product Portfolio
  36. 8.6.5 LFB Group Recent Developments
  37. 8.7 Kedrion
  38. 8.7.1 Kedrion Company Information
  39. 8.7.2 Kedrion Business Overview
  40. 8.7.3 Kedrion IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion IVIg Liquid Product Portfolio
  42. 8.7.5 Kedrion Recent Developments
  43. 8.8 Grifols
  44. 8.8.1 Grifols Company Information
  45. 8.8.2 Grifols Business Overview
  46. 8.8.3 Grifols IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Grifols IVIg Liquid Product Portfolio
  48. 8.8.5 Grifols Recent Developments
  49. 8.9 CSL
  50. 8.9.1 CSL Company Information
  51. 8.9.2 CSL Business Overview
  52. 8.9.3 CSL IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CSL IVIg Liquid Product Portfolio
  54. 8.9.5 CSL Recent Developments
  55. 8.10 CNBG
  56. 8.10.1 CNBG Company Information
  57. 8.10.2 CNBG Business Overview
  58. 8.10.3 CNBG IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CNBG IVIg Liquid Product Portfolio
  60. 8.10.5 CNBG Recent Developments
  61. 8.11 CBPO
  62. 8.11.1 CBPO Company Information
  63. 8.11.2 CBPO Business Overview
  64. 8.11.3 CBPO IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CBPO IVIg Liquid Product Portfolio
  66. 8.11.5 CBPO Recent Developments
  67. 8.12 BPL
  68. 8.12.1 BPL Company Information
  69. 8.12.2 BPL Business Overview
  70. 8.12.3 BPL IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BPL IVIg Liquid Product Portfolio
  72. 8.12.5 BPL Recent Developments
  73. 8.13 Biotest
  74. 8.13.1 Biotest Company Information
  75. 8.13.2 Biotest Business Overview
  76. 8.13.3 Biotest IVIg Liquid Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biotest IVIg Liquid Product Portfolio
  78. 8.13.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 IVIg Liquid Value Chain Analysis
  2. 9.1.1 IVIg Liquid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 IVIg Liquid Production Mode & Process
  6. 9.2 IVIg Liquid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 IVIg Liquid Distributors
  9. 9.2.3 IVIg Liquid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst